MENU
NKTR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nektar Therapeutics (NKTR) Ownership - Who owns Nektar Therapeutics?

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
63
Web
https://www.nektar.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.25B
P/E Ratio
N/A
Total Cash
568.6M
Projected Growth
N/A
Total Debt
83.16M
Revenue
55.63M
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
16.83
Total Debt/Equity
N/A
Revenue/Share
2.85 USD as % of share price
View a ticker or compare two or three
NKTR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
63
Web
https://www.nektar.com